• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产品开发伙伴关系:卫生技术创新新机制的案例研究。

Product Development Partnerships: Case studies of a new mechanism for health technology innovation.

机构信息

Dengue Vaccine Initiative International Vaccine Institute Seoul, Korea.

出版信息

Health Res Policy Syst. 2011 Aug 26;9:33. doi: 10.1186/1478-4505-9-33.

DOI:10.1186/1478-4505-9-33
PMID:21871103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3175464/
Abstract

There is a continuing need for new health technologies to address the disease burdens of developing countries. In the last decade Product Development Partnerships (PDP) have emerged that are making important contributions to the development of these technologies. PDPs are a form of public private partnerships that focus on health technology development. PDPs reflect the current phase in the history of health technology development: the Era of Partnerships, in which the public and private sectors have found productive ways to collaborate. Successful innovation depends on addressing six determinants of innovation. We examine four case studies of PDPs and show how they have addressed the six determinants to achieve success.

摘要

发展中国家面临着日益严重的疾病负担,因此需要不断开发新的医疗技术。在过去十年中,出现了一些产品开发伙伴关系(PDP),它们为这些技术的开发做出了重要贡献。PDP 是一种专注于医疗技术开发的公私伙伴关系形式。PDP 反映了医疗技术发展历史的当前阶段:合作时代,公共和私营部门已经找到了富有成效的合作方式。成功的创新取决于解决创新的六个决定因素。我们研究了四个 PDP 的案例,展示了它们如何解决这六个决定因素以取得成功。

相似文献

1
Product Development Partnerships: Case studies of a new mechanism for health technology innovation.产品开发伙伴关系:卫生技术创新新机制的案例研究。
Health Res Policy Syst. 2011 Aug 26;9:33. doi: 10.1186/1478-4505-9-33.
2
Enabling product development partnerships to bring forward the next generation of health technologies.促成产品开发合作关系,以推动下一代健康技术的发展。
Health Aff Sch. 2023 Dec 23;2(1):qxad088. doi: 10.1093/haschl/qxad088. eCollection 2024 Jan.
3
Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making.在中低收入国家采用新的卫生产品:产品开发伙伴关系如何支持国家决策。
Health Res Policy Syst. 2011 Mar 31;9:15. doi: 10.1186/1478-4505-9-15.
4
The influenza vaccine innovation system and lessons for PDPs.流感疫苗创新体系及对公私合作伙伴关系的启示。
Hum Vaccin Immunother. 2012 Mar;8(3):407-10. doi: 10.4161/hv.18701. Epub 2012 Feb 13.
5
Twenty-first century vaccinomics innovation systems: capacity building in the global South and the role of Product Development Partnerships (PDPs).二十一世纪疫苗学创新体系:全球南方的能力建设与产品研发伙伴关系(PDPs)的作用。
OMICS. 2011 Sep;15(9):539-43. doi: 10.1089/omi.2011.0036. Epub 2011 Jul 6.
6
Public-Private Partnerships and the Landscape of Neglected Tropical Disease Research: The Shifting Logic and Spaces of Knowledge Production.公私伙伴关系与被忽视热带病研究的格局:知识生产的逻辑与空间转变
Minerva. 2023 Jun 2:1-23. doi: 10.1007/s11024-023-09496-x.
7
Product Development Partnerships: Delivering Innovation for the Elimination of African Trypanosomiasis?产品开发伙伴关系:为消除非洲锥虫病带来创新?
Trop Med Infect Dis. 2020 Jan 15;5(1):11. doi: 10.3390/tropicalmed5010011.
8
How to Achieve Transparency in Public-Private Partnerships Engaged in Hunger and Malnutrition Reduction.如何在致力于减少饥饿与营养不良的公私伙伴关系中实现透明度。
World Rev Nutr Diet. 2016;115:224-32. doi: 10.1159/000442109. Epub 2016 May 19.
9
The role of Product Development Partnerships in research and development for neglected diseases.产品研发伙伴关系在研发被忽视疾病中的作用。
Int Health. 2010 Jun;2(2):114-22. doi: 10.1016/j.inhe.2010.04.002.
10
The introduction of new vaccines into developing countries. IV: Global Access Strategies.向发展中国家引进新疫苗。四:全球获取策略。
Vaccine. 2007 May 16;25(20):4003-11. doi: 10.1016/j.vaccine.2007.02.047. Epub 2007 Mar 7.

引用本文的文献

1
Therapeutic development to accelerate malaria control through intentional intervention layering.通过有意叠加干预措施来加速疟疾控制的治疗性开发。
Malar J. 2025 Jan 13;24(1):12. doi: 10.1186/s12936-024-05222-4.
2
Operational Differences between Product Development Partnership, Pharmaceutical Industry, and Investigator Initiated Clinical Trials.产品开发合作、制药行业和研究者发起的临床试验之间的运营差异。
Trop Med Infect Dis. 2024 Feb 29;9(3):56. doi: 10.3390/tropicalmed9030056.
3
The role of global health partnerships in vaccine equity: A scoping review.全球卫生伙伴关系在疫苗公平性方面的作用:一项范围综述。
PLOS Glob Public Health. 2024 Feb 22;4(2):e0002834. doi: 10.1371/journal.pgph.0002834. eCollection 2024.
4
Pull me - push you? The disparate financing mechanisms of drug research in global health.拉我一把——推你一下?全球卫生领域药物研究的不同融资机制
Global Health. 2024 Feb 19;20(1):14. doi: 10.1186/s12992-024-01019-x.
5
Implementation and impact of the global access principles at the University of British Columbia: current successes and future challenges.英属哥伦比亚大学全球准入原则的实施与影响:当前的成功与未来的挑战。
Front Pharmacol. 2023 Dec 15;14:1271618. doi: 10.3389/fphar.2023.1271618. eCollection 2023.
6
Public Health Value of a Hypothetical Pneumococcal Conjugate Vaccine (PCV) Introduction: A Case Study.一种假设的肺炎球菌结合疫苗(PCV)的公共卫生价值:案例研究介绍
Vaccines (Basel). 2022 Jun 15;10(6):950. doi: 10.3390/vaccines10060950.
7
Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development.从 COVID-19 中吸取的紧迫教训:世界为何需要一个常设的、协调一致的系统和可持续的资金,用于全球研发。
Lancet. 2021 Mar 27;397(10280):1229-1236. doi: 10.1016/S0140-6736(21)00503-1. Epub 2021 Mar 9.
8
An open-source molecular diagnostic platform approach for outbreak and epidemic preparedness.一种用于疫情防范的开源分子诊断平台方法。
Afr J Lab Med. 2020 Sep 28;9(2):1017. doi: 10.4102/ajlm.v9i2.1017. eCollection 2020.
9
Responding to maternal, neonatal and child health equipment needs in Kenya: a model for an innovation ecosystem leveraging on collaborations and partnerships.满足肯尼亚孕产妇、新生儿和儿童健康设备需求:一个利用合作与伙伴关系的创新生态系统模式。
BMJ Innov. 2020 Jul;6(3):85-91. doi: 10.1136/bmjinnov-2019-000391. Epub 2020 Apr 24.
10
Insights for the future of health system partnerships in low- and middle-income countries: a systematic literature review.低、中收入国家卫生系统伙伴关系的未来展望:系统文献回顾。
BMC Health Serv Res. 2020 Jun 22;20(1):571. doi: 10.1186/s12913-020-05435-8.

本文引用的文献

1
The role of Product Development Partnerships in research and development for neglected diseases.产品研发伙伴关系在研发被忽视疾病中的作用。
Int Health. 2010 Jun;2(2):114-22. doi: 10.1016/j.inhe.2010.04.002.
2
Forecasting dengue vaccine demand in disease endemic and non-endemic countries.预测登革热流行国家和非流行国家的登革热疫苗需求。
Hum Vaccin. 2010 Sep 1;6(9):745-53. doi: 10.4161/hv.6.9.12587.
3
The role of emerging manufacturers in access to innovative vaccines of public health importance.新兴制造商在获取具有公共卫生重要性的创新疫苗方面的作用。
Vaccine. 2010 Feb 25;28(9):2115-21. doi: 10.1016/j.vaccine.2009.12.036. Epub 2009 Dec 29.
4
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.一种改良的口服霍乱全细胞灭活疫苗在印度的疗效与安全性:一项整群随机、双盲、安慰剂对照试验的中期分析
Lancet. 2009 Nov 14;374(9702):1694-702. doi: 10.1016/S0140-6736(09)61297-6. Epub 2009 Oct 8.
5
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.蒿甲醚-本芴醇分散片与碾碎的市售片剂相比在非洲患单纯性疟疾的婴幼儿中的疗效和安全性:一项随机、单盲、多中心试验
Lancet. 2008 Nov 22;372(9652):1819-27. doi: 10.1016/S0140-6736(08)61492-0. Epub 2008 Oct 14.
6
"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation.《流行地区登革热疫苗临床评估指南》:世界卫生组织技术磋商会纪要
Vaccine. 2008 Aug 5;26(33):4113-9. doi: 10.1016/j.vaccine.2008.05.058. Epub 2008 Jun 11.
7
The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa.儿童霍乱负担沉重:亚洲和非洲流行地区发病率比较。
PLoS Negl Trop Dis. 2008 Feb 20;2(2):e173. doi: 10.1371/journal.pntd.0000173.
8
Private demand for cholera vaccines in Hue, Vietnam.越南顺化对霍乱疫苗的私人需求。
Value Health. 2008 Jan-Feb;11(1):119-28. doi: 10.1111/j.1524-4733.2007.00220.x.
9
Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.孟加拉国婴幼儿霍乱疫苗接种的保护作用:对疫苗推广及人传人传播的影响
Pediatr Infect Dis J. 2008 Jan;27(1):33-7. doi: 10.1097/INF.0b013e318149dffd.
10
Private demand for cholera vaccines in rural Matlab, Bangladesh.孟加拉国马特拉布农村地区对霍乱疫苗的个人需求。
Health Policy. 2008 Feb;85(2):184-95. doi: 10.1016/j.healthpol.2007.07.009. Epub 2007 Sep 5.